SCHEMBL20528787

SCHEMBL20528787

Cc1cc(OCc2c(F)cccc2F)c2nc(C)c(N)n2c1

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 1/20 0.46
ATP4B P51164 1/20 0.46
GUCY1B2 O75343 16/20 0.45
GUCY1A2 P33402 16/20 0.45
GUCY1A1 Q02108 16/20 0.45
GUCY1B1 Q02153 16/20 0.45
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18570328 0.88 CYP3A4 (0.52) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2
SCHEMBL19492087 0.86 GUCY1B2 (0.43) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2
SCHEMBL16403535 0.86 GUCY1B2 (0.45) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2
SCHEMBL17803134 0.85 GUCY1B2 (0.42) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2
SCHEMBL16403049 0.84 GUCY1B2 (0.47) GUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL16402801 0.84 GUCY1B2 (0.53) GUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL16402956 0.84 GUCY1B2 (0.46) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2
SCHEMBL19012013 0.84 ATP4A (0.48) ATP4AATP4BGUCY1B2GUCY1A2GUCY1A1
SCHEMBL20528798 0.83 ATP4A (0.67) ATP4AATP4BGUCY1B2GUCY1A2GUCY1A1
SCHEMBL16403544 0.83 GUCY1B2 (0.45) GUCY1B2GUCY1A2GUCY1A1GUCY1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227287-B1 HETEROARYL-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINES AND THEIR USE Bayer Pharma AG (DE) 2019-08-07 EP disclosed
WO-2018184976-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND USE OF SAME BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-10-11 WO disclosed